Endothelial microparticles
complexMicroparticles shed from activated/eroded endothelium reflecting endothelial damage and thrombotic potential.
Pathway placement
Cascade stepEndothelial activation & erosion
Confidencehigh
RationaleEndothelial dysfunction/activation marker; released from injured endothelium.
Also acts inPlatelet activation, Coagulation / thrombus
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I59
C — confounder / Type-II55
A — assay feasibility58
E — evidence strength24
T1DI (composite)7
Specificity differential (R−C)+3.7
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Plasma (citrate for coagulation complexes)
Collection tube
Sodium citrate 3.2% (light blue-top) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich ELISA against neo-complex epitope
Reagent / substrate
Antibody pair recognizing the assembled complex
Platform
ELISA plate
Turnaround · availability
Research / send-out · Research/specialized
Literature evidence(2)
- Cell-Derived Microparticles and Acute Coronary Syndromes: Is there a Predictive Role for Microparticles?Current medicinal chemistry · 2020 · PMID 31838988 · doi
- Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.BMC nephrology · 2019 · PMID 30823870 · doi